The growing importance of biobanks in the context of scientific research is evidenced by the recent accreditation of a significant facility operating in the field of human genetics. This biobank has received accreditation from the relevant authority, ensuring high standards in the management of biological material of human origin. The achievement of this important milestone was in accordance with the international standard UNI EN ISO 20387:2024, which sets specific requirements for biobanking.
The biobank in question is distinguished by its ability to manage various types of biological samples, as well as the handling of associated data. It collects material from individuals affected by genetic disorders, including peripheral blood, serum, plasma, circulating mononuclear cells (PBMC), urine, cerebrospinal fluid, genomic DNA, and cell lines. The capacity to handle such a variety of samples is essential for ensuring the quality of scientific research and allows for a structured and systematic approach to the challenges related to health and genetics.
With this accreditation, the biobank is among the few facilities of its kind in Italy, and its main objective is to collect, preserve, and manage biological samples in an organized manner, establishing a system for their distribution to support research and scientific development. Biobanks are not mere archives but true working tools that support the scientific community in conducting advanced studies and developing new biotechnologies.
The management of biological materials and clinical data is a crucial component in research, as it ensures the reproducibility and comparability of results. A standardized approach in sample treatment procedures—which extends from collection to transport, storage, traceability, and distribution—is essential to ensure that the results obtained are valid and reliable. Guiding this necessity is the UNI ISO 20387:2019 standard, which provides an international framework for biobanking, defining general requirements related to competence, impartiality, and functionality of the facilities.
The success achieved by the human genetics biobank is part of a context of increasing attention to biomedical research, which not only contributes to scientific progress but also offers significant opportunities for innovation in the health field. The applications of biotechnology are rapidly expanding, and according to OECD projections, this emerging sector will have a significant impact on the global economy, contributing 2.7% to the world’s GDP by 2030.
The biobank, with its specialization and accreditation, plays a strategic role in this landscape. The collection of biological samples helps to feed the databases necessary for advanced research, while the accreditation provides the guarantees required by the scientific community. This is essential for fostering collaborations, developing new therapies, and addressing the challenges posed by genetic diseases.
Moreover, the importance of an accredited biobank transcends national boundaries, contributing to the building of a cohesive and interconnected international research system. This approach allows for the harmonization of practices in sample collection and management, promoting the sharing of data and results among researchers from different countries. This exchange not only enriches the knowledge base but also accelerates scientific progress.
In conclusion, the biobank represents a fundamental resource for the future of biomedical research, laying the groundwork for the development of therapeutic and diagnostic innovations. This journey is accompanied by a continuous commitment to maintaining high standards of accreditation and management to ensure the quality and reliability of the collected data.
To stay updated on our activities and discoveries in the field of biomedical research, we invite you to follow our social media profiles. Your participation is essential for spreading knowledge and actively contributing to the advancement of science.
